SIRT6 and type 2 diabetes mellitus: Balestrieri et al. demonstrated that SIRT6 protein expression in atherosclerotic lesions of T2DM patients was downregulated, which was compared with SIRT6 protein expression in atherosclerotic lesions of non-diabetic patients, and the reduced SIRT6 expression was associated with increased oxidative stress and inflammation (81).